Cowen and Company’s SC Health Corporation Warrants, each whole warrant exercisable for one Class A ordinary share at an SCPE.WS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q2
Sell
-35,000
Closed -$66K 846
2021
Q1
$66K Buy
+35,000
New +$56.8K ﹤0.01% 361
2020
Q4
Sell
-50,000
Closed -$58K 588
2020
Q3
$58K Sell
50,000
-151,453
-75% -$162K 0.01% 295
2020
Q2
$218K Sell
201,453
-53,730
-21% -$54.7K 0.04% 198
2020
Q1
$244K Sell
255,183
-90,600
-26% -$90.2K 0.06% 176
2019
Q4
$332K Sell
345,783
-37,400
-10% -$40.4K 0.03% 160
2019
Q3
$460K Buy
+383,183
New +$452K 0.12% 110

Other funds holding SCPE.WS

Cowen and Company's SCPE.WS Position: Q2 2021 in Review

Cowen and Company sold out of SC Health Corporation Warrants, each whole warrant exercisable for one Class A ordinary share at an (SCPE.WS) in Q2 2021, closing a stake of 35,000 shares — an estimated $66K sold.

Cowen and Company first reported a position in SCPE.WS in Q3 2019 and held it in 6 quarters. The position peaked at $460K in Q3 2019. 16 funds tracked by Wall St. Rank hold SCPE.WS as of Q2 2021.

  • Cowen and Company reported no remaining SC Health Corporation Warrants, each whole warrant exercisable for one Class A ordinary share at an position as of Q2 2021 after selling out during the quarter.
  • Cowen and Company sold 35,000 SC Health Corporation Warrants, each whole warrant exercisable for one Class A ordinary share at an shares in Q2 2021, an estimated $66K.
  • Cowen and Company first reported a position in SC Health Corporation Warrants, each whole warrant exercisable for one Class A ordinary share at an in Q3 2019 and held it in 6 quarters.
  • Cowen and Company's SC Health Corporation Warrants, each whole warrant exercisable for one Class A ordinary share at an position peaked at $460K in Q3 2019.
  • 16 funds tracked by Wall St. Rank held SC Health Corporation Warrants, each whole warrant exercisable for one Class A ordinary share at an as of Q2 2021.

Based on Cowen and Company's 13F filing for Q2 2021, filed 13 Aug 2021.